BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29438260)

  • 21. Loss of Endothelial Endoglin Promotes High-Output Heart Failure Through Peripheral Arteriovenous Shunting Driven by VEGF Signaling.
    Tual-Chalot S; Garcia-Collado M; Redgrave RE; Singh E; Davison B; Park C; Lin H; Luli S; Jin Y; Wang Y; Lawrie A; Jakobsson L; Arthur HM
    Circ Res; 2020 Jan; 126(2):243-257. PubMed ID: 31805812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.
    Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Pérez-Molino A; Hebbel RP; Nguyen J; Bernabéu C; Botella LM
    Cardiovasc Res; 2005 Nov; 68(2):235-48. PubMed ID: 15993872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional analysis of a novel ENG variant in a patient with hereditary hemorrhagic telangiectasia (HHT) identifies a new Sp1 binding-site.
    Plumitallo S; Ruiz-Llorente L; Langa C; Morini J; Babini G; Cappelletti D; Scelsi L; Greco A; Danesino C; Bernabeu C; Olivieri C
    Gene; 2018 Mar; 647():85-92. PubMed ID: 29305977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia.
    Gallardo-Vara E; Tual-Chalot S; Botella LM; Arthur HM; Bernabeu C
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30108051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Executive summary of the 12th HHT international scientific conference.
    Andrejecsk JW; Hosman AE; Botella LM; Shovlin CL; Arthur HM; Dupuis-Girod S; Buscarini E; Hughes CCW; Lebrin F; Mummery CL; Post MC; Mager JJ
    Angiogenesis; 2018 Feb; 21(1):169-181. PubMed ID: 29147802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.
    Snodgrass RO; Chico TJA; Arthur HM
    Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
    Karlsson T; Cherif H
    Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.
    Kuehl HK; Caselitz M; Hasenkamp S; Wagner S; El-Harith el-HA; Manns MP; Stuhrmann M
    Hum Mutat; 2005 Mar; 25(3):320. PubMed ID: 15712270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of a mutation in the zona pellucida module of Endoglin that causes Hereditary Hemorrhagic Telangiectasia.
    Ruiz-Llorente L; Chiapparino E; Plumitallo S; Danesino C; Bayrak-Toydemir P; Pagella F; Manfredi G; Bernabeu C; Jovine L; Olivieri C
    Gene; 2019 May; 696():33-39. PubMed ID: 30763665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New genetic drivers in hemorrhagic hereditary telangiectasia.
    Cerdà P; Castillo SD; Aguilera C; Iriarte A; Rocamora JL; Larrinaga AM; Viñals F; Graupera M; Riera-Mestre A
    Eur J Intern Med; 2024 Jan; 119():99-108. PubMed ID: 37689549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor induces abnormal microvasculature in the endoglin heterozygous mouse brain.
    Xu B; Wu YQ; Huey M; Arthur HM; Marchuk DA; Hashimoto T; Young WL; Yang GY
    J Cereb Blood Flow Metab; 2004 Feb; 24(2):237-44. PubMed ID: 14747750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Executive summary of the 14th HHT international scientific conference.
    Ola R; Hessels J; Hammill A; Friday C; Clancy M; Al-Samkari H; Meadows S; Iyer V; Akhurst R
    Angiogenesis; 2023 Aug; 26(Suppl 1):27-37. PubMed ID: 37695357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary Vascular Complications in Hereditary Hemorrhagic Telangiectasia and the Underlying Pathophysiology.
    Bofarid S; Hosman AE; Mager JJ; Snijder RJ; Post MC
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of Hereditary Hemorrhagic Telangiectasia.
    Crist AM; Lee AR; Patel NR; Westhoff DE; Meadows SM
    Angiogenesis; 2018 May; 21(2):363-380. PubMed ID: 29460088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
    Abdalla SA; Letarte M
    J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoglin and activin receptor-like-kinase 1 are co-expressed in the distal vessels of the lung: implications for two familial vascular dysplasias, HHT and PAH.
    Mahmoud M; Borthwick GM; Hislop AA; Arthur HM
    Lab Invest; 2009 Jan; 89(1):15-25. PubMed ID: 19015642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model.
    Crist AM; Zhou X; Garai J; Lee AR; Thoele J; Ullmer C; Klein C; Zabaleta J; Meadows SM
    Circulation; 2019 Apr; 139(17):2049-2063. PubMed ID: 30744395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients.
    Lesca G; Burnichon N; Raux G; Tosi M; Pinson S; Marion MJ; Babin E; Gilbert-Dussardier B; Rivière S; Goizet C; Faivre L; Plauchu H; Frébourg T; Calender A; Giraud S;
    Hum Mutat; 2006 Jun; 27(6):598. PubMed ID: 16705692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis.
    Lenato GM; Suppressa P; Giordano P; Guanti G; Guastamacchia E; Triggiani V; Amati L; Resta F; Covelli V; Jirillo E; Sabbà C
    Curr Pharm Des; 2007; 13(36):3656-64. PubMed ID: 18220803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment.
    Ardelean DS; Jerkic M; Yin M; Peter M; Ngan B; Kerbel RS; Foster FS; Letarte M
    Angiogenesis; 2014 Jan; 17(1):129-46. PubMed ID: 24061911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.